FrancophonIA/ELRC3.0 huggingface dataset:
English: Another positive control group treated with a florfenicol monoproduct was used, however it should be noted that this product is not approved for the treatment of respiratory infections caused by M. bovis.
Maltese: Intuża grupp ieħor ta' kontroll pożittiv li rċieva kura b'monoprodott ta' florfenicol, madankollu għandu jiġi nnotat li dan il-prodott mhuwiex approvat għall-kura ta' infezzjonijiet respiratorji kkawżati minn M. bovis.
English: RESFLOR SOLUCIÓN INYECTABLE
Maltese: RESFLOR SOLUCIÓN
English: Overall summary of the scientific evaluation of Resflor solution injectable and associated names (see annex I)
Maltese: Sommarju ġenerali tal-evalwazzjoni xjentifika ta' Resflor soluzzjoni injettabbli u ismijiet assoċjati (ara anness I)
English: Resflor is therefore considered superior to the saline treatment and non-inferior to the combination tulathromycin-flunixin.
Maltese: Għalhekk Resflor huwa meqjus superjuri għall-kura bis-salina u mhuwiex inferjuri għal kombinazzjoni tulathromycin-flunixin.
English: The antipyretic response to tulathromycin or florfenicol treatment was clinically similar with statistically significant differences in favour of florfenicol on Days 2 and 3.
Maltese: Irrispons antipirettiku għall-kura b'tulathromycin jew b'florfenicol kien klinikament simili b'differenzi statistikament sinifikanti favur florfenicol fil-Jiem 2 u 3. Sal-aħħar tal-istudju (Jum 18), 61 minn 87 każ (70.
English: List of the name, pharmaceutical form, strength of the veterinary medicinal product, animal species, route of administration, marketing authorisation holder in the Member States
Maltese: Lista tal-isem, għamla farmaċewtika, qawwa tal-prodott mediċinali veterinarju, speċi tal-annimal, mod talamministrazzjoni ,sid tal-awtorizzazzjoni għat-tqegħid fuq is-suq fl-Istati Membri
English: From the data currently available, no particular risk of increase of M. bovis susceptibility to florfenicol is expected from the use of Resflor.
Maltese: Ma huwa mistenni l-ebda riskju partikolari ta' nuqqas fis-suxxettibbiltà ta' M. bovis għal florfenicol millużu ta' Resflor.
English: Amendments in the relevant sections of the summary of product characteristics, labelling and package leaflet
Maltese: Emendi fis-sezzjonijiet rilevanti tas-sommarju talkaratteristiċi tal-prodott, it-tikkettar u l-fuljett ta' tagħrif
English: Based on the current knowledge on Mycoplasma infections the use of the combination of florfenicol with flunixin will improve the clinical success rate over an antibiotic alone.
Maltese: Abbażi tal-għarfien attwali dwar infezzjonijiet b'Mycoplasma l-użu tal-kombinazzjoni ta' florfenicol ma' flunixin se jtejjeb ir-rata ta' suċċess kliniku fuq antibijotiku waħdu.